Skip to main content

CAPSTONE INVESTMENT ADVISORS, LLC

Position in GH — Guardant Health, Inc.

CIK 1426196 NEW YORK, NY

Position in GH

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$253,700
+$25,009 QoQ
Shares Held
1,691
-24.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#425
of 594 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Jun 30, 2022
CallValue
$677,712
CallShares
16,800
PutValue
$988,330
PutShares
24,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CAPSTONE INVESTMENT ADVISORS, LLC holds $2,327,741 across 6 Diagnostics & Research names. GH ranks #5 (10.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GH
Guardant Health, Inc.
This page
1,691 $253,700

All Filings in GH

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $253,700 1,691
2025-12-31 $228,691 2,239
2025-09-30 $2,361,681 37,799
2025-06-30 $787,989 15,142
2023-12-31 $337,259 12,468
2022-06-30 $988,330 24,500
2022-06-30 $970,661 24,062
2022-06-30 $677,712 16,800
2022-03-31 $1,622,880 24,500
2022-03-31 $464,011 7,005
2022-03-31 $1,112,832 16,800